Study of the Prevalence of Active/Passive Smoking and Vaping Among Patients With Cystic Fibrosis
Recruiting
Observational Study
Cystic Fibrosis
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In the collective unconscious, a patient with cystic fibrosis does not smoke. This belief is so deeply rooted that there is virtually no French data on the prevalence of smoking among this vulnerable population.
Faced with a cohort of patients undergoing a complete transformation (improved quality of life and life expectancy, fewer hospitalizations, reduced respiratory symptoms, better social int…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patient (≥ 18 years old)
* With confirmed cystic fibrosis
* Regular follow-up at the Strasbourg Adult Cystic Fibrosis Center
Exclusion Criteria:
* Patients who have undergone a double lung transplant for cystic fibrosis.
Contacts